GenSight Biologics
SIGHT.PA
S$0.24
Share price
6.94%
Change (1 day)
-46.65%
Change (1 year)
P/S ratio for GenSight Biologics (SIGHT.PA)
P/S ratio at the end of 2024: 21.5
According to GenSight Biologics's latest financial reports and stock price the company's current price-to-sales ratio (TTM) is -1.04. At the end of 2024 the company had a P/S ratio of 21.5.
P/S ratio history for GenSight Biologics from 2016 to 2024
PS ratio at the end of each year
| Year | P/S ratio | Change |
|---|---|---|
| 2024 | 21.5 | -8.8% |
| 2023 | 23.6 | -60.78% |
| 2022 | 60.1 | 23.51% |
| 2021 | 48.7 | -26.59% |
| 2020 | 66.3 | -42.94% |
| 2019 | 116 | |
| 2018 | N/A | |
| 2017 | N/A | |
| 2016 | N/A |